drugset / Trial / NCT00204516
Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of the vaccination protocol is to induce specific immune responses against melanoma associated antigens by intradermal injections of mRNA coding for the corresponding antigen.
Timeline
- Start
- 2007-04
- Primary completion
- 2011-08
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mRNA coding for melanoma associated antigens | Messenger RNA (mRNA) | — | Subcutaneous |
| Background | sargramostim | Protein / enzyme biologic | — | Subcutaneous |